MANE
NYSE ·

Veradermics Inc

Mid-Cap Stocks
$94.40
+1.42 (+1.53%)
As of Jun 11, 8:15 PM ET ·
MANE News1 articles
Veradermics Soars After Hair-Loss Drug Meets Trial Goals
Veradermics shares jumped 40% after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial, with patients seeing significant hair count increases.
Markets